Liver cancer is a global health challenge, causing a significant social-economic burden.
Hepatocellular carcinoma (HCC) is the predominant type of primary liver cancer, which is …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading
cause of cancer-related deaths worldwide. Although the prognosis of patients with HCC is …

Objective The lack of highly sensitive and specific diagnostic biomarkers is a major
contributor to the poor outcomes of patients with hepatocellular carcinoma (HCC). We …

Objective Hepatocellular carcinoma (HCC) has become a pressing health problem facing
the world today due to its high morbidity, high mortality, and late discovery. As a diagnostic …

The immunosuppressive microenvironment plays an important role in tumor progression
and immunotherapy responses. Golgi membrane protein 1 (GOLM1) is correlated to …

Despite advances in understanding the development and progression of cancer in recent
years, there remains a lack of comprehensive characterization of the cancer glycoproteome …

Hepatocellular Carcinoma (HCC) is one of the most common malignant tumours in the
world. It is a heterogeneous group of a tumour that vary in risk factor and genetic and …

Chronic hepatitis B virus (HBV) infection remains a global problem. Several HBV genotypes
exist with different biology and geographical prevalence. Whilst the future aim of HBV …

Tumor biomarkers are important in the early screening, diagnosis, therapeutic evaluation,
recurrence and prognosis prediction of tumors. Primary liver cancer is one of the most …

Current imaging technologies do not sufficiently detect micrometastasis and therefore do not
allow adequate stratification of patients with hepatocellular carcinoma (HCC) for curative or …